Publications by authors named "Sharon R Jackson"

Claim this Profile
F
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.
Paul G Richardson, Shaji K Kumar, Tamás Masszi, Norbert Grzasko, Nizar J Bahlis, Sharon R Jackson

J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinctive features of polycythaemia vera in New Zealand Polynesians.
Merit Z Hanna, Maggie L Kalev-Zylinska, Sharon R Jackson, Gordon Royle, Hilary A Blacklock

N Z Med J· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone . placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1.
María-Victoria Mateos, Tamas Masszi, Norbert Grzasko, Markus Hansson, Irwindeep Sandhu, Sharon R Jackson

Haematologica· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Philippe Moreau, Tamás Masszi, Norbert Grzasko, Nizar J Bahlis, Markus Hansson, Sharon R Jackson

N Engl J Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia.
David M Ross, Sharon R Jackson, Peter J Browett

Leuk Lymphoma· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis